ADARC

(redirected from Aaron Diamond AIDS Research Center)
Also found in: Wikipedia.
AcronymDefinition
ADARCAaron Diamond AIDS Research Center
ADARCAlcohol and Drug Abuse Research Center (Harvard University; Massachusetts)
References in periodicals archive ?
Reported by: LV Torian, PhD, S Blank, MD, SE Kellerman, MD, TR Frieden, MD, New York City Dept of Health and Mental Hygiene; DD Ho, MD, M Markowitz, MD, D Boden, MD, PhD, Aaron Diamond AIDS Research Center, New York City; MM Parker, PhD, S Philpott, PhD, New York State Dept of Health.
For more information about volunteering, contact Elizabeth Londono at The Aaron Diamond AIDS Research Center, 212-448-5126, or at aidsvaccine@adarc.
At the Aaron Diamond AIDS Research Center, he leads a team of some 50 world-class researchers studying this unique disease.
Every time HIV concentrations rise, immune cells suffer, says David Ho of the Aaron Diamond AIDS Research Center in New York City.
The new anti-viral drugs have cut the AIDS death rate by 50 percent in the last two to three years," reports Linqui Zhang, PhD, assistant professor at the Aaron Diamond AIDS Research Center at New York City's Rockefeller University.
director of the Aaron Diamond AIDS Research Center in New York City and the 1996 Time Man of the Year, revealed a bold new strategy utilizing protease-inhibitors in combination with standard antiviral medications, a therapy used by more and more doctors with increasing success.
David Ho, an author of one of the studies and a researcher at the Aaron Diamond AIDS Research Center in Manhattan, N.
Marx of the Aaron Diamond AIDS Research Center and colleagues report their findings in the journal Nature Medicine.
s R&D facility in Des Plaines, IL, as well as, the Aaron Diamond AIDS Research Center for the City of New York.
In the 1990s his lab at New York City's Aaron Diamond AIDS Research Center, which Ho helped found, yielded pioneering insights into the years-long battle waged between HIV and the human body's immune system.
On September 26 scientists at the Aaron Diamond AIDS Research Center (ADARC) announced that they had identified a significant contributor to a long-sought antiviral factor, secreted by certain CD8 T-cells, that inhibits HIV replication.
Decreased CTL activity had also been observed in early-disease patients who had been treated from 45 to 90 days after symptomatic acute infection, according to a study published 2 years earlier by researchers from the Aaron Diamond AIDS Research Center (ADARC) in New York and colleagues.